# Timolol-Brinzolamide

## Azarga 0.5/1% 5mL ophthalmic suspension

| 藥物代碼 | EAZA |
| :--- | :--- |
| 適應症 | Treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma |
| 副作用 | Taste perversion \(2%\), Blurred vision \(6%\), eye irritation \(4%\), eye pain \(3%\), foreign body sensation in eyes \(1%\) |
| 禁忌 | Hypersensitivity to brinzolamide, timolol, other beta-blockers, sulfonamides, or any component of the formulation; current or history of bronchial asthma; severe chronic obstructive pulmonary disease \(COPD\); severe allergic rhinitis and bronchial hyper-reactivity; sinus bradycardia, second-/third degree atrioventricular \(AV\) block, overt cardiac failure, cardiogenic shock; hyperchloremic acidosis; severe renal impairment |
| 藥物保存方式 | 室溫 |
| 用法用量 | Reduction of intraocular pressure: Ophthalmic: Instill 1 drop in affected eye\(s\) twice daily. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | Human data suggest risk in 2nd and 3rd trimester |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | \(Up to date\) Pregnancy Implications: There are no adequate and well-controlled studies in pregnant women with the combination product. Use only if benefit outweighs risk. Bradycardia and arrhythmia have been reported in an infant following ophthalmic administration of timolol during pregnancy. See individual agents. Lactation: Timolol enters breast milk/not recommended |
| 注射劑給藥建議途徑 | OD, OL, OU |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

